Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669694 · ClinicalTrials.gov registry record
Pelvic Floor Physical Therapy-Biomarkers Project
A clinical trial, sponsored by Kenneth Peters, MD.
- Completed
- Registry status
- 59
- Enrollment target
NCT01669694: Completed study, sponsored by Kenneth Peters, MD.
NCT01669694 is a clinical trial that has completed, run by Kenneth Peters, MD. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01669694 has completed, sponsored by Kenneth Peters, MD.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
This study is collecting serum and urine samples at various time points during pelvic floor physical therapy for women with pelvic pain.The biomarkers will be analyzed for cytokines and proteomics at various time points.
Primary Outcome
Interim Analysis to be done as PI determines.
Interventions
- OTHER Pelvic floor PT with biomarkers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-10 |
What the finished NCT01669694 record still lists
NCT01669694 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pelvic floor PT with biomarkers is the first listed.
NCT01669694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01669694 about?
NCT01669694 is a clinical study titled "Pelvic Floor Physical Therapy-Biomarkers Project". This study is collecting serum and urine samples at various time points during pelvic floor physical therapy for women with pelvic pain.The biomarkers will be analyzed for cytokines and proteomics at various time points.
What is the current status of trial NCT01669694?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2011-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01669694?
The interventions under investigation include: Pelvic floor PT with biomarkers (OTHER).
Who is sponsoring clinical trial NCT01669694?
This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia